VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 69 filers reported holding VERVE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,219,230 | +294400.0% | 91,948 | +220.6% | 0.00% | – |
| Q1 2023 | $414 | -100.0% | 28,679 | -59.3% | 0.00% | -100.0% |
| Q3 2022 | $2,418,000 | -57.4% | 70,400 | -81.1% | 0.00% | -75.0% |
| Q2 2022 | $5,679,000 | -77.0% | 371,671 | -9.3% | 0.00% | -73.3% |
| Q2 2021 | $24,702,000 | – | 409,994 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alphabet Inc. | 10,974,011 | $661,184,000 | 13.47% |
| Casdin Capital, LLC | 3,038,167 | $183,050,000 | 4.65% |
| Logos Global Management LP | 758,265 | $45,685,000 | 3.84% |
| Novo Holdings A/S | 793,265 | $47,794,000 | 2.12% |
| Redmile Group, LLC | 1,936,530 | $116,676,000 | 1.73% |
| Cormorant Asset Management, LP | 709,224 | $40,594,000 | 1.38% |
| Rock Springs Capital Management LP | 962,826 | $58,011,000 | 1.15% |
| Asymmetry Capital Management, L.P. | 24,790 | $1,494,000 | 1.03% |
| Darwin Global Management, Ltd. | 103,013 | $6,207,000 | 1.00% |
| RA Capital Management | 880,284 | $53,037,000 | 0.85% |